Condition

Blepharitis (2)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

Kala Pharmaceuticals, Inc. (1)

Merck Sharp & Dohme LLC (1)

Collaborator

Intervention

azithromycin ophthalmic solution, 1% (1)

kpi-121 (1)

placebo (1)

vehicle (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Blepharitis

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Blepharitis Trial in United States (KPI-121, Vehicle)

Completed

Blepharitis

Birmingham, Alabama
+7 more

Jan 6, 2021

Blepharitis Trial in United States (Azithromycin ophthalmic solution, 1%, Placebo)

Completed

Blepharitis

Azithromycin ophthalmic solution, 1%
Placebo

Little Rock, Arkansas
+32 more

Sep 20, 2011